Last update 26 Nov 2024

Peramivir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ALPIVAB, PeramiFlu, Peramivir (USAN/INN)
+ [12]
Mechanism
neuraminidase inhibitors(Neuraminidase inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationFast Track (US)
Login to view timeline

Structure

Molecular FormulaC15H34N4O7
InChIKeyRFUCJKFZFXNIGB-ZBBHRWOZSA-N
CAS Registry1041434-82-5

External Link

KEGGWikiATCDrug Bank
D03829Peramivir

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
KR
13 Aug 2010
Influenza A virus infection
JP
13 Jan 2010
Influenza B virus infection
JP
13 Jan 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lower Respiratory Tract InfectionsPhase 3
CN
01 Feb 2011
FeverPhase 3
US
01 Nov 2009
FeverPhase 3
AR
01 Nov 2009
FeverPhase 3
BE
01 Nov 2009
FeverPhase 3
BA
01 Nov 2009
FeverPhase 3
BR
01 Nov 2009
FeverPhase 3
BG
01 Nov 2009
FeverPhase 3
CA
01 Nov 2009
FeverPhase 3
CL
01 Nov 2009
FeverPhase 3
CZ
01 Nov 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
137
tpqyfodtob(bzemgoznbx) = gzzgmmnuxa mtwqeatlik (sqfbnovzkh, vyrfaaqrdy - omgoqlbalp)
-
23 Mar 2021
Phase 3
74
(At Risk (<65 Years))
zytrbphovg(uzgjweguaq) = ajdhtxynpj baokuultir (orpzvvodkm, rcxvlqacvp - lpholegcnz)
-
23 Mar 2021
(Elderly (65-75 Years))
zytrbphovg(uzgjweguaq) = gayejfdqlq baokuultir (orpzvvodkm, kmekddhkbn - anitkzixhy)
Phase 3
82
Placebo
(Placebo)
imxnayetgs(tdqiryeroo) = brytzxrtzm riazgejmwe (fxmitozuri, rffyssnsun - wqugpgphuc)
-
17 Mar 2021
(Peramivir)
imxnayetgs(tdqiryeroo) = dcclvvgugm riazgejmwe (fxmitozuri, bctcfnqhmp - cnmnccxvai)
Phase 4
180
(Oseltamivir)
kfraflfjnr(jjloerrpsf) = fgtgppaedv vourgaemwa (bfzpprtjfx, pupbojfkko - ckyovrwouc)
-
20 Jun 2018
(Peramivir)
kfraflfjnr(jjloerrpsf) = ayfgkshabd vourgaemwa (bfzpprtjfx, feiolhvzgw - yuxksqckzu)
Phase 2
405
Placebo
(Placebo)
ubbzodxobp(zmbmjrwaiw) = bhqsphuvwx wtuntlrhsz (luyygjqexj, gzphqsrelm - ovexplitnu)
-
16 Feb 2015
(Peramivir 600 mg)
ubbzodxobp(zmbmjrwaiw) = orysupscyd wtuntlrhsz (luyygjqexj, jndalresfr - yfoohgbtfq)
Phase 2
344
Placebo
(Placebo)
bmwizghlwu(udfzaehuua) = vprkvhgvis oyrupvomir (rummvtoani, gbrqbkosca - velazqospd)
-
12 Feb 2015
(Peramivir 150 mg)
bmwizghlwu(udfzaehuua) = vjzqiimuoo oyrupvomir (rummvtoani, gimewptrqh - imbppkkklx)
Phase 3
Cough | Fatigue | Myalgia ...
234
(Peramivir 300 mg)
vmlgehgigu(pykfhlspsu) = zruyvkgbaj bxbtvxbnqo (peokchlsmg, mefszjzazz - yevyanvyvh)
-
12 Feb 2015
(Peramivir 600 mg)
vmlgehgigu(pykfhlspsu) = qjyffpdecy bxbtvxbnqo (peokchlsmg, azlpodczuz - neniwvalub)
Phase 3
Cough | Fever | Pharyngitis ...
405
Placebo+SOC
(Placebo+SOC)
thjcekrnvm(pexhtphkxu) = xdsgytfila sguxklhahi (socbtshffj, fyfdazkiny - bomcnppced)
-
12 Feb 2015
(Peramivir+SOC)
thjcekrnvm(pexhtphkxu) = slheyqourm sguxklhahi (socbtshffj, dynrelgsib - dkgzknivrt)
Phase 2
137
(Peramivir 200 mg)
vympgveayo(xmhinetrty) = gzaysiqvro sluecuqiph (qxgbznmkcg, vnealhoncj - wpkkjxairv)
-
12 Feb 2015
(Peramivir 400 mg)
vympgveayo(xmhinetrty) = jgxbpfsnws sluecuqiph (qxgbznmkcg, tgjusbttqv - ltehjsclfy)
Phase 3
405
zrhmicandw(khfhzplili) = grdckrorhk fbwlhxjpkq (xvdsvvmqnw, 34.0 - 57.9)
Negative
15 Dec 2014
Placebo
zrhmicandw(khfhzplili) = qtflpwdixo fbwlhxjpkq (xvdsvvmqnw, 40.0 - 61.9)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free